Treatment with BF provided beneficial effects in patients with carnitine palmitoyltransferase-II (CPT-II) deficiency [16], although other studies reported conflicting results [17, 18]. This evidence concerns the gene CPT2 and hyperinsulinemic hypoglycemia, familial, 4.